Henan Lingrui Pharmaceutical Co Ltd Working Capital to Net Assets Ratio
Henan Lingrui Pharmaceutical Co Ltd working capital to net assets ratio. Henan Lingrui Pharmaceutical Co Ltd (600285) has a Working Capital to Net Assets ratio of 10.2% as of March 2026. Working capital of CN¥375.24 Million (current assets of CN¥2.57 Billion minus current liabilities of CN¥2.19 Billion) is measured against net assets of CN¥3.69 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Henan Lingrui Pharmaceutical Co Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Henan Lingrui Pharmaceutical Co Ltd (1997–2025)
Working capital to net assets ratio of Henan Lingrui Pharmaceutical Co Ltd from 1997 to 2025. This chart shows how Henan Lingrui Pharmaceutical Co Ltd's Working Capital to Net Assets ratio has evolved across 29 annual periods from 1997 to 2025. As of March 2026, the ratio stands at 10.2%, reflecting working capital of CN¥375.24 Million against net assets of CN¥3.69 Billion CNY. See how many days can Henan Lingrui Pharmaceutical Co Ltd fund operations to measure how many days the company can operate on defensive assets alone.
Henan Lingrui Pharmaceutical Co Ltd Working Capital to Net Assets Ratio by Year (1997–2025)
Henan Lingrui Pharmaceutical Co Ltd working capital to net assets ratio by year from 1997 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Henan Lingrui Pharmaceutical Co Ltd from 1997 to 2025, covering 29 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Henan Lingrui Pharmaceutical Co Ltd balance sheet assets.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 4.8% | CN¥164.31 Million | CN¥3.44 Billion | CN¥2.28 Billion | CN¥2.12 Billion | ▼ -14.2 pp |
| 2024 | 18.9% | CN¥583.70 Million | CN¥3.08 Billion | CN¥2.46 Billion | CN¥1.87 Billion | ▼ -6.0 pp |
| 2023 | 25.0% | CN¥698.77 Million | CN¥2.80 Billion | CN¥2.60 Billion | CN¥1.90 Billion | ▼ -6.2 pp |
| 2022 | 31.1% | CN¥796.44 Million | CN¥2.56 Billion | CN¥2.51 Billion | CN¥1.71 Billion | ▲ +0.8 pp |
| 2021 | 30.3% | CN¥693.59 Million | CN¥2.29 Billion | CN¥2.13 Billion | CN¥1.44 Billion | ▼ -6.3 pp |
| 2020 | 36.6% | CN¥850.28 Million | CN¥2.32 Billion | CN¥1.92 Billion | CN¥1.07 Billion | ▲ +3.3 pp |
| 2019 | 33.4% | CN¥740.57 Million | CN¥2.22 Billion | CN¥1.75 Billion | CN¥1.01 Billion | ▲ +2.2 pp |
| 2018 | 31.1% | CN¥652.19 Million | CN¥2.09 Billion | CN¥1.59 Billion | CN¥942.62 Million | ▲ +3.6 pp |
| 2017 | 27.6% | CN¥607.74 Million | CN¥2.20 Billion | CN¥1.62 Billion | CN¥1.01 Billion | ▼ -10.6 pp |
| 2016 | 38.2% | CN¥806.12 Million | CN¥2.11 Billion | CN¥1.56 Billion | CN¥756.72 Million | ▲ +29.0 pp |
| 2015 | 9.1% | CN¥157.39 Million | CN¥1.72 Billion | CN¥942.57 Million | CN¥785.18 Million | ▲ +5.2 pp |
| 2014 | 4.0% | CN¥61.86 Million | CN¥1.56 Billion | CN¥820.69 Million | CN¥758.83 Million | ▼ -23.1 pp |
| 2013 | 27.0% | CN¥266.39 Million | CN¥984.89 Million | CN¥839.55 Million | CN¥573.17 Million | ▲ +14.4 pp |
| 2012 | 12.7% | CN¥88.48 Million | CN¥696.97 Million | CN¥575.33 Million | CN¥486.85 Million | ▼ -9.3 pp |
| 2011 | 22.0% | CN¥150.32 Million | CN¥684.01 Million | CN¥577.57 Million | CN¥427.25 Million | ▼ -3.3 pp |
| 2010 | 25.3% | CN¥179.46 Million | CN¥709.69 Million | CN¥571.07 Million | CN¥391.61 Million | ▲ +11.5 pp |
| 2009 | 13.8% | CN¥89.02 Million | CN¥645.69 Million | CN¥436.39 Million | CN¥347.37 Million | ▼ -3.1 pp |
| 2008 | 16.9% | CN¥92.95 Million | CN¥549.72 Million | CN¥505.37 Million | CN¥412.42 Million | ▼ -10.3 pp |
| 2007 | 27.2% | CN¥157.53 Million | CN¥579.24 Million | CN¥488.32 Million | CN¥330.79 Million | ▲ +1.7 pp |
| 2006 | 25.5% | CN¥124.14 Million | CN¥486.67 Million | CN¥500.40 Million | CN¥376.26 Million | ▼ -23.0 pp |
| 2005 | 48.5% | CN¥232.62 Million | CN¥479.80 Million | CN¥489.58 Million | CN¥256.96 Million | ▲ +5.9 pp |
| 2004 | 42.6% | CN¥199.77 Million | CN¥469.45 Million | CN¥451.64 Million | CN¥251.87 Million | ▼ -5.7 pp |
| 2003 | 48.2% | CN¥217.78 Million | CN¥451.69 Million | CN¥395.98 Million | CN¥178.19 Million | ▼ -0.6 pp |
| 2002 | 48.8% | CN¥203.43 Million | CN¥416.74 Million | CN¥400.05 Million | CN¥196.63 Million | ▼ -21.2 pp |
| 2001 | 70.0% | CN¥281.23 Million | CN¥401.79 Million | CN¥366.74 Million | CN¥85.50 Million | ▼ -18.6 pp |
| 2000 | 88.6% | CN¥362.00 Million | CN¥408.46 Million | CN¥426.74 Million | CN¥64.73 Million | ▲ +40.0 pp |
| 1999 | 48.6% | CN¥30.20 Million | CN¥62.08 Million | CN¥126.89 Million | CN¥96.70 Million | ▼ -22.4 pp |
| 1998 | 71.0% | CN¥35.42 Million | CN¥49.85 Million | CN¥80.91 Million | CN¥45.49 Million | ▲ +10.3 pp |
| 1997 | 60.8% | CN¥20.65 Million | CN¥33.98 Million | CN¥54.52 Million | CN¥33.87 Million | — |